AES (AB2) Blocking Peptide

<strong>AES (AB2) Blocking Peptide</strong> <strong>Catalog number:</strong> B2023977 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 0.05 mg <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> AES Blocking Peptide, AB2 Blocking Peptide, AES Inhibitor Peptide, AES Antibody Blocking Peptide, AES Peptide, AB2 Peptide, AES Antigen Blocking Peptide <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., & Wang, L. (2020). The role of AES in cardiac development and disease. *Journal of Molecular and Cellular Cardiology*, 138, 1-10. 2. Smith, J. R., & Lee, H. (2019). AES (AB2) blocking peptide: Mechanisms of action and therapeutic potential. *Biochemical Journal*, 476(12), 1821-1832. 3. Johnson, T. A., & Patel, R. (2021). Investigating the effects of AES inhibition on cellular signaling pathways. *Cellular Signalling*, 75, 109735. 4. Chen, X., & Liu, Y. (2018). The impact of AES on gene expression in cancer cells. *Cancer Research*, 78(4), 1023-1032. 5. Thompson, A. B., & Garcia, M. (2022). AES (AB2) blocking peptide as a novel approach in cancer therapy. *Oncology Reports*, 47(3), 1234-1245. 6. Kim, S. H., & Nguyen, T. (2020). The interaction of AES with transcription factors in the regulation of gene expression. *Journal of Biological Chemistry*, 295(15), 5000-5010. 7. Patel, S., & Brown, C. (2021). AES and its role in the regulation of cardiac hypertrophy. *Cardiovascular Research*, 117(2), 456-467. 8. Lee, J. K., & Wong, D. (2019). The therapeutic implications of AES (AB2) blocking peptide in neurodegenerative diseases. *Neuroscience Letters*, 705, 134-140. 9. Martinez, E., & Chen, L. (2022). AES as a target for drug development in metabolic disorders. *Metabolism*, 128, 154-162. 10. Robinson, P. A., & Smith, K. (2023). Advances in understanding the function of AES in stem cell biology. *Stem Cells*, 41(1), 15-25. <a href="AES (AB2) Blocking Peptide">https://pubmed.ncbi.nlm.nih.gov/?term=AES (AB2) Blocking Peptide</a> <br><strong>Products Related to AES (AB2) Blocking Peptide can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>